Disease control with prior platinum-based chemotherapy is prognostic for survival in patients with metastatic urothelial cancer treated with atezolizumab in real-world practice
By: Marina Mencinger, Dusan Mangaroski and Urska Bokal
Authors
Marina Mencinger
Institute of Oncology Ljubljana, Ljubljana, Slovenia
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Dusan Mangaroski
Institute of Oncology Ljubljana, Ljubljana, Slovenia
Urska Bokal
Institute of Oncology Ljubljana, Ljubljana, Slovenia
Language: English
Page range: 491 - 498
Submitted on: Sep 27, 2021
Accepted on: Mar 7, 2021
Published on: May 4, 2021
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2021 Marina Mencinger, Dusan Mangaroski, Urska Bokal, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.